High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer - Wikidata - awgldk - TriplyDB

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer

http://www.wikidata.org/entity/Q24648804

about

SAFB2, a new scaffold attachment factor homolog and estrogen receptor corepressor Structure-function analysis of the estrogen receptor alpha corepressor scaffold attachment factor-B1: identification of a potent transcriptional repression domain SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cells Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.Multivariate Boosting for Integrative Analysis of High-Dimensional Cancer Genomic Data.No germline mutations in supposed tumour suppressor genes SAFB1 and SAFB2 in familial breast cancer with linkage to 19p.Drosophila SAF-B links the nuclear matrix, chromosomes, and transcriptional activity MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer Quantitative proteomic identification of the BRCA1 ubiquitination substrates.Scaffold Attachment Factor B1 (SAFB1) heterozygosity does not influence Wnt-1 or DMBA-induced tumorigenesis Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer.SAFB1- and SAFB2-mediated transcriptional repression: relevance to cancer.Scaffold attachment factor B (SAFB)1 and SAFB2 cooperatively inhibit the intranuclear mobility and function of ERα.A novel member of the SAF (scaffold attachment factor)-box protein family inhibits gene expression and induces apoptosis.RanBP3 enhances nuclear export of active (beta)-catenin independently of CRM1.Identification of proteins binding to E-Box/Ku86 sites and function of the tumor suppressor SAFB1 in transcriptional regulation of the human xanthine oxidoreductase gene.Enhancer of rudimentary homologue interacts with scaffold attachment factor B at the nuclear matrix to regulate SR protein phosphorylation.Genetic Instability in Locus rs5498 E469K (A/G) of ICAM-1 Gene in Patients with Colorectal Cancer and Breast Cancer

P2860

Q24298578-130B6A32-5862-443C-8147-FB9BF4D2F4EE Q28254928-BDFAADC5-535C-4240-9218-408A488BA792 Q28264289-85BCDEE4-BB8C-48E0-B7EE-30358DC64CA1 Q30476046-61C3C112-4EF7-445B-9740-41B8A81E9701 Q31028324-DC516773-C72E-49AB-87F9-DBFE5C448F21 Q33392484-B4801B4F-6944-4651-B8A1-50312D2657A6 Q33565682-88A7D808-DFF2-43F3-9A03-B8D2193ACC96 Q34169595-6FC68176-8625-4F37-8EEB-8FA77873ABF7 Q35529345-18E68E5D-DA2C-41F8-9DE5-A4B4FF6A4B08 Q37158467-4C8CE1B7-FD85-4426-B6D6-FBE969434A2C Q37618471-40870C36-5DE1-4FD9-AB98-FCCA651B7F53 Q38027968-60DF6E48-A012-4571-81BD-C6F0F8051AED Q39352152-23B75F2A-07E7-4D1E-A7B4-45DBDFA1DB54 Q40107151-FF374A6F-8A87-4B6C-B039-9B55108C18DC Q40346466-8CA04942-DA5C-48F4-AADE-6084C6A23B33 Q42275228-52098F16-4986-4E77-94E4-C4C17FB691D4 Q46348230-0FA68400-9051-4B52-BCC0-BD861B3FA818 Q57692220-C994B4B4-375C-44FF-9E04-12A936AF2E4B

P2860

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer

http://www.wikidata.org/entity/Q24648804

description

2001 nî lūn-bûn

@nan

2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer

@ast

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer

@en

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer

@nl

type

label

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer

@ast

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer

@en

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer

@nl

prefLabel

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer

@ast

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer

@en

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer

@nl

P1433

Q24648804-54463803-AB90-479B-9C6F-CF37B5C4F385

P1476

Q24648804-8EA95DFF-B4CC-4520-835C-5ED3F8B15E28

P2093

Q24648804-0C44B389-39FF-4210-8A50-5F2C98D1CC1E

Q24648804-2E0E68FC-E19C-42D9-ABA5-EC20B54F7C33

Q24648804-55421BDD-9800-4872-A2B9-9B253A36A29B

Q24648804-61AD6C25-DA24-4E57-B688-50BF8FC34311

Q24648804-67336959-A21F-43FF-9F51-0C8C4E0878C4

Q24648804-68C10E92-9D62-45A1-8516-5D61CCEDB729

Q24648804-7EB03C57-75C0-4A5F-B6D5-4A55C3DAED02

Q24648804-9AECBB1B-C86B-48EC-854D-C2B8C4B4B0FC

P2860

Q24648804-2EB5511E-A353-418C-8434-73D27C7218E7

Q24648804-466B0A6B-9EDA-4FFB-BF15-6F24B10142FD

Q24648804-4DE10238-E701-4159-95F4-8946EFC43088

Q24648804-4E6B205F-9B65-4529-A820-619B0EF33820

Q24648804-59CE6388-3441-4738-9CDC-B862993A8816

Q24648804-6E05FB96-D0E5-4755-9544-5AEE2966B101

Q24648804-6E41F011-FA94-4E01-B14A-266FC1B73ABB

Q24648804-78B4763E-2F80-41B5-B1D4-EF3E8516D53F

Q24648804-78BD978D-CA79-46F4-A827-3635F6D851D2

Q24648804-79C28415-A5E4-4B9E-A93B-5EB3237B2669

P2888

Q24648804-FA033B35-13AE-4EDA-ADAF-5D07F900CD0F

P304

Q24648804-57267B80-A470-4B6B-BCB4-96398D6D5189

P31

Q24648804-FDE89025-1EFD-4368-AD09-AABABB268FB5

P356

Q24648804-70212AE4-FFCF-4B24-BE1D-49F6D0251A2B

P407

Q24648804-BEE21BBF-3615-4A8F-BC9A-B4CE93A2689C

P433

Q24648804-F9CF4B02-3B9F-4740-BC2D-0499F0262A3C

P478

Q24648804-9E3C1E45-DDFA-4F3F-9727-EE63879B226D

P577

Q24648804-AFBEA875-3493-47B3-9AD4-4F4E28754D7F

P5875

Q24648804-190C1A99-0FA8-4FA0-9F0F-94121B4AA69F

P6179

Q24648804-EC031AD5-1A17-4860-873A-FFDAE14006D6

P698

Q24648804-D87FB21C-259E-4018-B1F3-6FE87777BA03

P932

Q24648804-FC7CD807-E36E-4D72-96BC-395493524BAD

P356

P1433

British Journal of Cancer

P1476

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer

@en

P2093

A V Lee

http://www.w3.org/2001/XMLSchema#string

C K Osborne

http://www.w3.org/2001/XMLSchema#string

D C Allredl

http://www.w3.org/2001/XMLSchema#string

H Wong

http://www.w3.org/2001/XMLSchema#string

P O'Connell

http://www.w3.org/2001/XMLSchema#string

Q Zhang

http://www.w3.org/2001/XMLSchema#string

S K Mohsin

http://www.w3.org/2001/XMLSchema#string

S Oesterreich

http://www.w3.org/2001/XMLSchema#string

P2860

An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens

Human RanBP3, a group of nuclear RanGTP binding proteins

Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor

Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor

A novel SH3-containing human gene family preferentially expressed in the central nervous system

The GDB Human Genome Database Anno 1997

Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer

Assignment of SAFB encoding Hsp27 ERE-TATA binding protein (HET)/scaffold attachment factor B (SAF-B) to human chromosome 19 band p13

P2888

P304

493-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1054/BJOC.2000.1606

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

2001-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12124298

http://www.w3.org/2001/XMLSchema#string

P6179

1035628945

http://www.w3.org/2001/XMLSchema#string

P698

11207044

http://www.w3.org/2001/XMLSchema#string

P932

2363776

http://www.w3.org/2001/XMLSchema#string